Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ménoactiv is a non-hormonal dietary supplement developed by Laboratoires Élerté specifically for the management of symptoms associated with menopause, such as hot flashes, night sweats, and fatigue. Its primary active component is a purified cytoplasmic pollen extract (PureCyTonin complexes A and B), which is thought to alleviate vasomotor symptoms through a non-estrogenic mechanism, likely involving the central nervous system's thermoregulatory center. The formulation is enriched with a specific blend of vitamins and minerals, including Vitamin B6 for hormonal regulation, Vitamin E for antioxidant protection, and Vitamins D3 and K2 to support bone health. Magnesium is also included to help reduce fatigue and support normal psychological function. It is intended as an alternative for women who cannot or choose not to use hormone replacement therapy (HRT).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ménoactiv.